COMBINED THERAPY BASED ON CD20 ANTIBODY AND BTK INHIBITOR

• 收藏
• 分享

专利权人:

发明人:

申请号：

RU2016122232

公开号：

RU2016122232A3

申请日:

申请国别(地区):

RU

年份:

2018

代理人:

摘要：

The present invention is directed to the combination therapy of an anti-CD20 antibody with a BTK inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with a type I anti-CD20 antibody or an afucosylated humanized B-Ly1 antibody and a BTK inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/